{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-23-002150","form_type":"8-K","ticker":"AGPU","cik":"0001446159","company_name":"Axe Compute Inc.","filed_at":"2023-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.900636+00:00","generated_at":"2026-06-17T05:48:51.192425+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Predictive Oncology dismisses Baker Tilly, engages BDO as new auditor for FY2023","bullets":["Dismissed Baker Tilly as independent auditor effective April 3, 2023; no disagreements on accounting principles or audit scope.","Engaged BDO USA as new independent auditor for year ending December 31, 2023, approved by Audit Committee and Board.","Baker Tilly's reports on FY2022 and FY2021 financials were unqualified; no adverse opinions or modifications.","Company previously disclosed material weakness in internal control over financial reporting (inadequate GAAP resources).","No consultations with BDO on accounting principles or audit opinions prior to engagement."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-23-002150","json":"https://secwatch.observer/filing/0001171843-23-002150.json","markdown":"https://secwatch.observer/filing/0001171843-23-002150.md","text":"https://secwatch.observer/filing/0001171843-23-002150.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323002150/0001171843-23-002150-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323002150/f8k_040423.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T05:48:51.192425+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0b4837e54d08aa40f004f8a6bf63da4428c00640","claim":"Axe Compute Inc. engaged BDO USA, LLP as its auditor.","evidence_excerpt":"udit Committee and the Board of Directors approved the engagement of BDO USA, LLP (“BDO”) as the Company’s new independent registered public accounting firm to audit the Company’s consolidated financial statements commencing for the year ending December","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323002150/0001171843-23-002150-index.htm","confidence":1.0,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"BDO USA, LLP"}],"fact_type":"auditor_change"},{"claim_id":"c20c91ffb22d6bef67eea89d60e3aac3a7c0054d","claim":"Axe Compute Inc. dismissed Baker Tilly US, LLP as its auditor.","evidence_excerpt":"Dismissal of Independent Registered Public Accounting Firm On April 3, 2023, Predictive Oncology Inc. (the “Company”) and Baker Tilly US, LLP (“Baker Tilly”) agreed that Baker Tilly, who was previously engaged as the Company’s independent registered public accounting firm, would be dismissed as the independent registered public accounting firm of the Company in connection with auditing the Company’s consolidated financial statements commencing for the year","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1446159/000117184323002150/0001171843-23-002150-index.htm","confidence":1.0,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"Baker Tilly US, LLP"},{"label":"Successor","value":"BDO USA, LLP"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}